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Abstract
A retrospective epidemiological and diagnostic study of visceral
leishmaniasis (VL) was carried out during the period 2001–2007
and included patients suspected of VL who had been diagnosed
at the Parasitological Laboratory at the Institute for Infectious
and Tropical Diseases, Belgrade. Diagnosis of VL was conﬁrmed
by microscopic examination of Giemsa-stained bone marrow
(BM) smears. BM smears from 134 patients were examined; 22
cases of VL were diagnosed, the majority of which involved indi-
viduals who had been on holiday at the Montenegrian sea coast.
The sensitivity of the initial BM smears was inadequate; this
required the application of a serological test, adapted for routine
use, for the diagnosis of VL.
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The epidemiology of leishmaniasis is extremely diverse, with
12 million people infected worldwide [1]. In the Mediterra-
nean basin, visceral leishmaniasis (VL) is caused by Leishmania
infantum, known as ‘Mediterranean kala-azar’ (MVL). The
diagnosis of MVL is complex and requires detection of
parasites in bone marrow (BM) smears [2]. Sporadic
autochthonous cases of VL have occurred in southern Serbia
(unpublished data). An epidemiological and diagnostic study
of VL was carried out at the Institute of Infectious and
Tropical Diseases in Belgrade, where most VL cases are
treated.
The study was carried out from January 2001 to Decem-
ber 2007 and included two groups (one of patients with sus-
pected VL and one control group). Informed consent was
obtained from all patients. Suspected VL was deﬁned on the
basis of a history of fever of ‡14 days with either clinical
splenomegaly or wasting syndrome. Clinical suspicion was
strengthened if the patient was from an endemic area or had
travelled to one in the recent past. Deﬁnitive diagnosis of VL
was based on direct microscopic demonstration of amastig-
otes in the BM smear. If the initial BM smear was negative
but the clinical index of suspicion was high, parasitological
investigation was repeated, or the diagnosis was based on
the clinical picture and positive serology.
All patients with suspected VL (n = 134) were examined
by performing a Giemsa-stained BM smear. BM aspirates
were obtained by sternal puncture or, if the quality of the
sternal aspirate was poor, by iliac crest biopsy. Starting in
December 2004, 26 patients were further tested using the
strip-test [3] and an indirect haemagglutination assay (IHA).
The Rapid Dipstick rK39 test (strip-test; DiaSys Europe Ltd,
Wokingham, UK) is a qualitative membrane-based immunoas-
say using the recombinant antigen K39, which is part of the
L. chagasi kinesin-related protein and is speciﬁc for all mem-
bers of the L. donovani complex [4]. In the IHA (Behring
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Diagnostics GmbH, Marburg, Germany), human erythrocytes
sensitized with L. donovani antigen agglutinate in the presence
of L. donovani antibodies. The IHA was considered positive at
a titre of >1:64.
The control group included 57 patients with other diagno-
ses, who were tested using IHA and the strip-test, but no
BM aspiration.
In evaluation of each of the three methods, sensitivity and
specifcity were calculated, sensitivity was calculated as
(TP)100/(TP+FN), speciﬁcity was callculated as (TN)100
(TN+FP), where TP is the number of patients with true-posi-
tive results, FN is the number of patients with false-negative
results, TN is the number of patients with false-positive
results [5].
A total of 159 BM smears from 134 patients was examined:
134 of sternal punctures and 25 of iliac crest biopsies. Twenty-
two patients had VL. The infections were contracted in Mon-
tenegro (n = 16, 72%), Herzegovina (n = 3, 13%), southern
Serbia, Kosovo, or another southern European country [n = 1
(5%) each]. Six patients (27.3%) had different pre-existent dis-
eases. The medium duration of illness before presenting to the
investigating hospital was > 4 months. The initial examination
of BM smears was successful in 86.36% (19/22) of the patients.
Among 26 patients suspected of having VL who were
tested with the three diagnostic methods, 10 had VL. At
the ﬁrst examination, two had negative BM smears. In only
one patient was the parasitological investigation repeated
and VL conﬁrmed. In another patient, the diagnosis was
based on the clinical picture, serology and therapeutic effect
(Table 1). The strip-test was the most sensitive test
(100%), followed by IHA (90%) and the initial examination
of BM smears (80%). Nine patients with VL had signiﬁcant
antibody titres as determined with IHA. All patients with
imported malaria and other infectious and non-infectious
diseases scored negative according to both the strip-test
and IHA (Table 2).
In former Yugoslavia, VL was endemic in Macedonia,
southern Serbia, the Montenegro coast, the south of Herz-
egovina and Dalmatia [6]. During the period 1945–1955,
three epidemic waves of VL were recorded in Serbia. In the
subsequent 3 years, only 17 cases were reported, the result
of eradication of malaria vectors [7]. Rare autochthonous
cases were noticed in 1968 and 1969 in Nis, where Phleboto-
mus major, P. simic´i and P. perﬁliewi were identiﬁed [6].
According to epidemiological data, 39 VL cases were
reported in Serbia and Montenegro from 1991 to 2000, with
only one case being imported. In central Serbia, the
incidence was 0.01/100 000 in 2007. The transmission was
probably zoonotic, but animal reservoirs were unknown.
The predominant VL risk in the study patients was a stay
at the Montenegrian sea coast, where as many as ten cases
have been diagnosed each year in Bar [8]. Although a single
case originated in southern Serbia, this could imply a dor-
mant focus and a necessity of surveillance.
The long average duration of disease before a diagnosis
was established in the study patients is the result of (i) pre-
TABLE 1. Characteristics of ten VL patients tested in parallel using three diagnostic methods from December 2004 to
December 2007
Patient
Age/
gender
Origin of
patients Clinical presentation
Pre-existent
diseases
IHA
titre
Strip-test
result Initial BM smear
1 24/M South Serbia Fever, sweats, weight loss, pancytopenia,
hepatosplenomegaly
No 1:1024 + +
Numerous amastigotes
2 68/F Montenegro sea-coast Fever, pancytopenia, hepatosplenomegaly Sarcoidosis 1:256 + +
Moderate amastigotes
3 27/M Herzegovina Fever, heavy sweating, bicytopenia,
hepatosplenomegaly
No 1:1024 + +
Numerous amastigotes
4 28/F Montenegro sea-coast Fever, weight loss, splenomegaly Ulcerative colitis 1:128 + )b
5 68/F Herzegovina Fever, pancytopenia, hepatosplenomegaly Diabetes mellitus,
anemia
1:2048 + )c
6 63/F Montenegro sea-coast Fever, fatigue, cough, weight loss, muscular pain,
hepatosplenomegaly
No 1:16384 + +
Numerous amastigotes
7 44/M Montenegro sea-coast Thrombocytopenia, skin rash, hepatosplenomegaly No 1:16384 + +
Numerous amastigotes
8 33/F Montenegro sea-coast Fever, pancytopenia, moderate hepatosplenomegaly Chronic meningo
-encephalitisa
1:2048 + +
Numerous amastigotes
9 22/M Herzegovina Fever, night sweats, cough, fatigue, weight loss,
pancytopenia, hepatosplenomegaly
No 1:32± + +
Rare amastigotes
10 69/M Montenegro sea-coast Fever, headache, bicytopenia, cough, night sweats,
fatigue, muscular pain, arthralgia, hepatosplenomegaly
Chronic renal failure,
diabetes mellitus
1:6536 + +
Rare amastigotes
aSurgery for lumbar meningocoelae; congenital hydrocephalus.
bParasitological investigation was repeated and Vh was conﬁrmed (rare amastigotes were found).
cBM aspiration was not repeated. Diagnosis was based on clinical picture, positive serology and therapeutic effect.
M, male; F, female; +, positive; ), negative.
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existing diseases that can mimic VL [9,10], (ii) the diversity
of the clinical pictures, and (iii) the rare incidence of VL
(explaining why clinicians are not familiar with this disease)
[1].
The sensitivity of BM smear examination is estimated at
70% or lower [11]. The number of ﬁelds and the duration
of observation may augment the sensitivity [12]. In our
hands, high sensitivity (86.36%) was expected since our
microscopic examination included up to 1000 oil immersion
ﬁelds, depending on the density of amastigotes. Smears
were reported negative after only 1 h of microscopic exam-
ination.
The strip-test has the advantage of easy handling and quick
results and it allows the detection of active VL [4,13]. How-
ever, the sensitivity varied considerably in different endemic
areas. Sensitivity was highest in India and Nepal (100%)
[11,13], but was signiﬁcantly lower in southern Europe
(71.4%) [3] and Sudan (67%) [14]. These variations may be
the result of different subspecies of L. donovani complexes, of
differences in the genetic background of the patients, and/or
of differences in the duration and severity of the disease
[15].
The IHA and strip-test were negative with sera of patients
in the control group, contrary to previous reports [16]. The
density of Leishmania amastigotes and the antibody titres
according to IHA were not always correlated with each
other (patient 10) or with the clinical condition (patients 4
and 9). Introduction of molecular methods for the detection
of Leishmania species could contribute to explain these dis-
crepancies.
The inadequate sensitivity of BM smear examination
required the application of serological tests, adapted for rou-
tine use, to diagnose VL reliably. Although the sensitivity and
speciﬁcity of both tests appeared satisfactory, their use in only
a small number of cases precludes deﬁnitive conclusions. Their
further evaluation in the study population is recommended.
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Abstract
Staphylococcus saprophyticus is a common cause of uncomplicated
urinary tract infections and is usually susceptible to the antimi-
crobial agents used for their treatment. However, S. saprophyticus
resistant to b-lactam antibiotics and carrying mecA has been
reported. Eight Swedish isolates of mecA-positive S. saprophyticus
with diverse origin carrying at least three different types of
staphylococcal cassette chromosome mec (SCCmec) are
described here.
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Staphylococcus saprophyticus, a coagulase-negative staphylococ-
cus, is a common cause of uncomplicated urinary tract infec-
tions (UTI) in young and sexually active women. Routine
laboratory identiﬁcation of S. saprophyticus is mainly made on
the basis of resistance to novobiocin, absence of haemolysis,
and negative tests for coagulase and/or DNase. Staphylococcus
saprophyticus is usually susceptible to the antimicrobial agents
used for treatment of UTI.
However, during the late summer in 2007, three iso-
lates of S. saprophyticus were noted at the Department of
Clinical Microbiology, O¨rebro University Hospital, Sweden,
that were resistant to ampicillin and cephadroxil as deter-
mined by disc diffusion test (AB Biodisk, Solna, Sweden)
according to the Swedish Reference Group for Antibiotics
(SRGA, http://www.srga.org). Detection of mecA was per-
formed by using a multiplex PCR adapted for the LightCy-
cler System with SYBR Green I as described previously
[1], and the three isolates were found to carry the mecA
gene. A retrospective survey of S. saprophyticus isolated
from the period 2000–2008 revealed in 15 urine samples
containing S. saprophyticus regarded as resistant to cephadr-
oxil. Five of these isolates had been stored at )70C and
were subsequently further analysed. In addition, these ﬁve
isolates were mecA-positive. Altogether, eight isolates were
characterized by pulsed-ﬁeld gel electrophoresis (PFGE) of
chromosomal SmaI digests as described [1] and deter-
mined to the species level by ID32Staph (bioMe´rieux,
Marcy l’Etoile, France).
Determination of the staphylococcal cassette chromosome
mec (SCCmec) type I, II, III, IV and V was performed as
described [2] except for the class B mec complex, which was
identiﬁed according to Okuma et al. [3].
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